[Expression of metallothionein-3 in esophageal cancer and its correlations to expression of metallothionein-1 and -2].
Metallothionein (MT)-3 can inhibit cell growth. Up to now, it is the only MT subtype with specific physiological function. This study was to investigate the expression of MT-3 in esophageal cancer and its correlations to the expression of MT-1 and MT-2. The expression of MT-1, -2 and -3 in 76 specimens of esophageal cancer and 10 specimens of esophageal diverticulum were detected by SP immunohistochemistry. The correlations of MT-3 expression to MT-1 and MT-2 expression were analyzed. The expression level of MT-3 was significantly higher in esophageal cancer than in para-cancer normal tissues and benign esophageal lesions (Chi2=74.696, P<0.001). In tumor tissues, MT-3 was mainly expressed in cytoplasm. The expression level of MT-3 was related with differentiation (P=0.004), TNM stage (P=0.033), lymph node metastasis (P=0.017) and survival time (P=0.035), and negatively correlated to the expression levels of MT-1 and MT-2 (r=0.247, P=0.032). MT-3 is overexpressed in esophageal cancer. Its expression is closely related with the differentiation, development and prognosis of esophageal cancer, and its roles are obviously different from those of MT-1 and MT-2.